Navigation Links
Good Clinical Practice Journal Awards: Winners Announced

LONDON, September 7 /PRNewswire/ -- Clinical research professionals from all over the world gathered at the Gibson Hall in London last night for the inaugural Good Clinical Practice Journal (GCPj) Awards. Opening this landmark event, Chairman of the Commission on Human Medicines Professor Sir Gordon Duff said the awards were a most important celebration of innovation and enterprise in the development of new medicines. "I hope it will become a traditional event in the public health calendar", he told the 200+ audience.

The host for the evening, Dr Phil Hammond, a GP, writer, broadcaster and comedian, mixed laughter - "the best form of medicine according to the ho ho ho holistic humour institute!" with more serious issues. He bemoaned the poor headlines in the press relating to the pharmaceutical industry, clinical trials and the NHS and stressed the need for an awards programme like the GCPj Awards to highlight the achievements of clinical research.

GCPj editor Jenine Willis said "These awards are GCPj's chance to show industry's commitment to improving healthcare through innovative, high quality, rigorous clinical research. Better healthcare not only benefits society as a whole, it has a direct impact on the global economy and raising quality of life everywhere. Of course this is a serious business, but GCPj launched these awards to celebrate these achievements and tell the wider world about them too."

Individuals, teams and organisations were recognised by the 11 awards categories. The first company to receive an accolade was Pfizer who won the Most Successful Global Trial, which was sponsored by the global clinical research organisation (CRO) Kendle. The trial in question recruited renal cancer patients at 101 sites in 11 countries.

Accepting the award, Deborah Roberts from Pfizer UK Oncology said "It's an honour and a privilege to accept this award on behalf of all of the Pfizer team who have worked to develop Sutent and have through this made a significant difference to the lives of thousands of renal cancer patients and their families. The main thing for me after working for 11 years in oncology is to have patients ringing up to say thank you."

Another notable winner was South Africa's Aurum Institute for Health Research. It picked up the Most Innovative Patient Recruitment Strategy award for the Thibela TB Study, which used innovative communication techniques to enrol over 38,000 miners to the study. Dr Audrey Banyni, of the Mine Health and Safety Council in South Africa, said: "I am more than happy. In fact, ecstatic. It is a challenging trial because we are involving different mining organisations. The participants are from very different cultural backgrounds, including Zulus and people from Mozambique. We also have the involvement of the labour movement. So it is actually a great achievement for Aurum."

One of the key individual awards of the evening was the Clinical Research Professional of the Year, which was sponsored by the UK Institute of Clinical Research. The winner, Dr Richard Schulz from the CRO Chiltern International in the Czech Republic was praised for being a role model to both CRO and site staff, inspiring them to achieve outstanding result, particularly in an emerging region.

The Clinical Research Team of the Year was sponsored by global CRO i3, and the award was presented to Novartis Pharma's Aclasta/Reclast Horizon RFT Team. Accepting the award on behalf of their colleagues Dr Erik Eriksen and Dr Phil McKernan explained their team "...spread across the Atlantic, half of them were in the US and half were in Basel. So there was a lot time challenges. But the main challenge was that the trial was outsourced to a great extent and to co-ordinate that effort was a testimony to the teams on both sides of the Atlantic. And it has resulted in rapid approval by both the FDA and the CHMP."

The Clinical Research Programme which Best Promoted Access to Medicine was awarded to MDS Pharma Services. The judges called the Phase III Malaria Trial of Eurartekin "an excellent example of a public/private collaboration to find effective and affordable treatments for a widespread debilitating condition prevalent in many developing countries." In response, Dr James Pusey from MDS Pharma Services said "the trial is a major step forward in helping to treat and prevent a terrible disease in under developed countries. We are very proud to be part of the team that made this happen."

As the evening drew to a close Saul Shiffman collected the GCPj Lifetime Achievement Award for his work in developing patient-reported outcome measures and e-diaries for clinical research.

More details of the event, together with pictures and winners' responses, will be published in a special supplement, "The GCPj Awards 2007", in October. Photos are also available on request.

The Winners and Sponsors

Most Successful Global Trial

Sponsored by Kendle

Winner - A Phase III, randomized study of SU011248 versus interferon-alfa

as first-line systemic therapy for patients with metastatic renal cell

carcinoma - Pfizer Global Research and Development

Most Successful Company or Programme of the Year in Raising GCP Standards

Sponsored by Trial Trove

Winner - Good Clinical Data Management Practices Document - Society for

Clinical Data Management

Best Technological Development in Clinical Trial Management Systems

Sponsored by PAREXEL

Winner - ClinPhone Drug Accountability solution - ClinPhone

Best Technological Development in Planning and Educational Tools in

Clinical Trials

Sponsored by PAREXEL

Winner - SecureConsent - Consent Solutions Inc

Project Manager of the Year

Sponsored by MDS Pharma Services

Winner - Shemus Dore, Senior Data Management Project Manager, ICON

Most Innovative Patient Recruitment Strategy

Sponsored by Pharmaprojects

Winner - Thibela TB Study - Aurum Institute for Health Research

Academic Researcher of the Year

Sponsored by Institute of Clinical Research (India) and Cranfield


Winner - Professor Neil Marlow, Professor of Neonatal Medicine, Academic

Division of Child Health, Queen's Medical Centre, Nottingham; and

Honorary Consultant Paediatrician, Queen's Medical Centre, Nottingham

University Hospitals NHS Trust, UK

Clinical Research Professional of the Year

Sponsored by the Institute of Clinical Research

Winner - Dr Richard Schulz, Country Manager Czech Republic, Chiltern


Clinical Research Team of the Year

Sponsored by i3

Winner - Aclasta/Reclast Horizon RFT Team - Novartis Pharma AG

Clinical Research Programme that Best Promoted Access to Medicine

Sponsored by Partnerships in Clinical Trials 2007

Winner - Large-scale Phase III Malaria Trial of Eurartekin - MDS Pharma


GCPj Lifetime Achievement Award

Winner - Dr Saul Shiffman

Good Clinical Practice Journal (GCPj) is the monthly, subscription magazine chosen by dedicated research professionals. It aids awareness, interpretation and implementation of the regulations that affect global clinical trials. GCPj helps bring drugs to market faster through commitment to excellence in all aspects of clinical research. Request a free trial at

For further press details contact:

Peter Rixon, Special Projects Editor

Tel: +44-(0)20-7017-6948


Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing skills ... patients and their families pay tribute to a genetic counselor by nominating him or ... Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome magazine ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... D.C. (PRWEB) , ... June 24, 2016 , ... ... Heroes Golf Classic Tournament held on June 20th at the Woodmont Country Club ... charity, Luke’s Wings, an organization dedicated to helping service members that have been wounded ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: